⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23420259 | 0.72 | — | — | |
| SCHEMBL11293445 | 0.68 | — | — | |
| SCHEMBL17192854 | 0.68 | — | — | |
| SCHEMBL13842684 | 0.67 | — | — | |
| SCHEMBL11301005 | 0.67 | — | — | |
| SCHEMBL12831357 | 0.67 | — | — | |
| SCHEMBL340554 | 0.67 | — | — | |
| SCHEMBL1261724 | 0.67 | — | — | |
| SCHEMBL3610599 | 0.67 | — | — | |
| SCHEMBL9380426 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101711170-B | Gold-coated stent coated/plated the chemicals and oligonucleotide binding gold-coated stent and process for producing the same | BIONEER CORP | 2013-06-12 | — | — | CN | claimed |
| CN-101711170-A | Gold-coated stent coated/plated the chemicals and oligonucleotide binding gold-coated stent and process for producing the same | BIONEER CORP | 2010-05-19 | — | — | CN | claimed |
| JP-63207490-A | — | — | None | — | — | JP | disclosed |
| US-8597959-B2 | Methods of use of solid support material for binding biomolecules | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-12-03 | — | — | US | disclosed |
| CN-101711170-B | Gold-coated stent coated/plated the chemicals and oligonucleotide binding gold-coated stent and process for producing the same | BIONEER CORP | 2013-06-12 | — | — | CN | disclosed |
| EP-2423204-A1 | THIAZOLIDINONE DERIVATIVE | SBI Biotech Co., Ltd. (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-7863304-B2 | Analogs of glycyl-prolyl-glutamate | NEUREN PHARMACEUTICALS LIMITED (NZ) | 2011-01-04 | — | — | US | disclosed |
| US-20100184103-A1 | METHODS OF USE OF SOLID SUPPORT MATERIAL FOR BINDING BIOMOLECULES | 3M INNOVATIVE PROPERTIES COMPANY | 2010-07-22 | — | — | US | disclosed |
| CN-101711170-A | Gold-coated stent coated/plated the chemicals and oligonucleotide binding gold-coated stent and process for producing the same | BIONEER CORP | 2010-05-19 | — | — | CN | disclosed |
| US-7667046-B2 | N-sulfonyldicarboximide containing tethering compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-02-23 | — | — | US | disclosed |
| US-7423155-B2 | N-sulfonyldicarboximide containing tethering compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-09-09 | — | — | US | disclosed |
| US-20080145335-A1 | Analogs of Glycyl-Prolyl-Glutamate | NEUREN PHARMACEUTICALS LIMITED (NZ) | 2008-06-19 | — | — | US | disclosed |
| US-20080145907-A1 | N-SULFONYLDICARBOXIMIDE CONTAINING TETHERING COMPOUNDS | 3M INNOVATIVE PROPERTIES COMPANY | 2008-06-19 | — | — | US | disclosed |
| US-7361767-B2 | N-sulfonyldicarboximide containing tethering compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-04-22 | — | — | US | disclosed |
| US-7351838-B2 | N-sulfonyldicarboximide containing tethering compounds | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-04-01 | — | — | US | disclosed |
| US-20070154937-A1 | N-SULFONYLDICARBOXIMIDE CONTAINING TETHERING COMPOUNDS | 3M INNOVATIVE PROPERTIES COMPANY | 2007-07-05 | — | — | US | disclosed |
| US-20050227076-A1 | N-sulfonyldicarboximide containing tethering compounds | 3M INNOVATIVE PROPERTIES COMPANY | 2005-10-13 | — | — | US | disclosed |
| US-20050106709-A1 | N-sulfonyldicarboximide containing tethering compounds | 3M INNOVATIVE PROPERTIES COMPANY | 2005-05-19 | — | — | US | disclosed |
| JP-S63207490-A | FLUX FOR SOLDERING | NEOS CO LTD | 1988-08-26 | — | — | JP | disclosed |